🦊/Companies

Tbd

Acquired

3 known investors

Find your way into Tbd

Wisp offers online treatment and telemedicine for women and their partners, providing prescription treatments delivered to patients along with provider messaging and delivery tracking. It serves patients nationwide across the US in the digital women's health and sexual/reproductive health space.

Also known as TBD Health · TBD Health Inc. · tbd.health

Investors · 3

Company profile

researched Aug 2026

TBD Health is a sexual health company providing at-home STI testing nationwide in the United States alongside in-person testing through a network of more than 2,000 testing centers, plus two of its own clinics located in Las Vegas, Nevada and Denver, Colorado. Orders can be placed online or by phone without a doctor's referral; samples are collected locally without an appointment, results are generally returned in three to five days, and every test includes a clinical consultation and prescription medication where clinically appropriate, together with unlimited private messaging with clinicians.

The product catalog covers multi-analyte STI panels (3-panel, 5-panel, 7-panel and 9-panel, plus a 3-site oral, rectal and genital chlamydia/gonorrhea test), individual tests for bacterial vaginosis, HPV and mycoplasma genitalium, a PrEP HIV prevention program, and contraceptive care including birth control and generic Plan B One-Step, as well as a combined STD test and Plan B bundle. The Las Vegas clinic is listed with the CDC's National Prevention Information Network as a clinic offering on-site chlamydia, gonorrhea, hepatitis A/B/C, herpes, syphilis and rapid and conventional HIV testing, condom distribution, HIV and STI prevention education, doxy PEP, PEP and PrEP, family planning, HPV vaccination, HIV and hepatitis treatment, and PrEP navigation, with some free HIV and hepatitis B and C testing and fee-based PrEP for the uninsured.

TBD Health Inc. was acquired by Wisp, Inc., and the tbd.health domain now presents Wisp's direct-to-consumer offering: online treatment for bacterial vaginosis, yeast infection, UTI, genital herpes and cold sores, birth control, period delay via norethindrone acetate, levonorgestrel, at-home testing and diagnostics, PCOS support, menopause care, migraine care, a sleep aid, vaginal probiotics and longevity products.

Business model

Direct-to-consumer, cash-pay sexual and reproductive health services: patients purchase test panels or treatments online at transparent flat prices with no insurance required, and clinical consultation and any resulting prescription are bundled into the product price. Prescriptions are sent to a local pharmacy for same-day pickup or shipped free to the patient's home in discreet packaging. The company also markets a partnerships/B2B channel.

Per-order product pricing for test panels and treatments — for example $99 for the 3-panel, $149 for the 5-panel and $299 for the 7-panel STD test — with clinical consult and prescription included; purchases are FSA/HSA eligible. Birth control is offered in 1-, 3- and 6-month supplies.

Traction

The tbd.health site states the combined brand is trusted by over 1.8 million people nationwide and displays a 4.3 out of 5 average review score; the in-person testing page cites 4.9 out of 5 and access to more than 2,000 testing centers nationwide.

Latest developments

TBD Health Inc. was acquired by Wisp, Inc., as disclosed in a notice of acquisition on the tbd.health site; the domain's homepage and about page now serve Wisp-branded sexual, reproductive and women's health offerings, including newly promoted at-home testing and diagnostics, BV partner therapy, PCOS support, menopause care, migraine care, vaginal probiotics, a sleep aid and longevity products, plus a patient mobile app.

Full profile — market position, technology, go-to-market, geography

Market position

Positions itself as a non-judgmental, insurance-free sexual health provider combining at-home and in-person testing with included clinical care and prescriptions; the post-acquisition Wisp-branded site cites more than 1.8 million people served nationwide and an average customer rating of 4.3 out of 5, while the in-person testing page cites a 4.9 out of 5 rating.

Bundles clinician consultation, unlimited private messaging and prescription treatment into the price of every test, offers both nationwide at-home kits and same-day in-person appointments without a referral or appointment at partner sites, requires no insurance, and ships in discreet packaging with FSA/HSA eligibility.

Technology

Telehealth workflow combining online ordering and symptom triage, laboratory testing at partner collection sites or via at-home kits, asynchronous secure messaging and phone follow-up with licensed providers, e-prescribing to local pharmacies or fulfillment by mail, and a patient mobile app for ordering, delivery tracking and provider messaging. The company describes its patient data handling as privacy-focused with military-grade security.

Go-to-market

Online direct-to-consumer sales through tbd.health with ordering by web or phone, supported by a symptoms quiz, email marketing with a first-order discount, a partnerships/B2B page, and a consumer mobile app on the App Store and Google Play for existing patients to order treatment, track delivery and message providers. Physical access is provided via 2,000+ third-party testing centers and company clinics in Las Vegas and Denver.

Consumers seeking private sexual and reproductive health care in the US, including women and their partners, people seeking or maintaining PrEP, and, per the Las Vegas clinic listing, adolescents and youth, LGBTQ people, men who have sex with men, low-income and at-risk persons, pregnant women, and people living with HIV or hepatitis.

Geography

Nationwide across the United States for at-home testing and telehealth treatment, with in-person testing at over 2,000 partner testing centers and two owned clinics in Las Vegas, Nevada (8 E Charleston Blvd, Las Vegas, NV 89104, Clark County) and Denver, Colorado.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
3-panel STD test priceJan 2026$99
5-panel STD test priceJan 2026$149
7-panel STD test priceJan 2026$299
Average customer review ratingJan 20264.3 out of 5
Owned clinicsJan 20262 clinics
Partner testing centersJan 20262,000 locations
Patients servedJan 20261,800,000 people

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Timeline · 2

launches, deals, and filings
Jan 2026
TBD Health Inc. acquired by Wisp, Inc.

A notice of acquisition on the tbd.health site states that TBD Health Inc. was recently acquired by Wisp, Inc., and that all applicable references to TBD Health now refer to Wisp, Inc.

source ↗

Jan 2026
Patient mobile app for ordering, delivery tracking and provider messaging

Existing patients can download an app on the App Store and Google Play to order treatment, track delivery and message providers.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

Research sources · 8

primary sources listed
  • Tbdtbd.health · web

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Tbd do?
TBD Health is a US sexual and reproductive health company offering at-home and in-person STI testing with included clinical care; now part of Wisp.
Who are Tbd's investors?
Tbd's investors include Expansion Venture Capital, Swizzle Ventures, Human Ventures.